Investigating a new treatment pathway for Type 1 Diabetes
Official title: Mechanistic and Therapeutic Role of the TLR4 Signaling Pathway in Type 1 Diabetes
Funded at University of California at Davis · NIH-10915582 · Data updated 2026-11-12
This study is looking at a special antibody that might help people with Type 1 Diabetes by boosting certain immune cells to protect the insulin-producing cells in the pancreas, with hopes of creating a new treatment that works better for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project start | September 1, 2023 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $657,760 |
| NIH project number | 5R01DK136815-02 |
| Project ID | NIH-10915582 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Type 1 Diabetes who are experiencing challenges with current treatment options.
✕Less likely to help
Patients with Type 2 Diabetes or those whose diabetes is not autoimmune in nature may not benefit from this research.
What this research studies
This research focuses on understanding how a specific antibody targeting the TLR4 signaling pathway can reverse Type 1 Diabetes (T1D) by activating immune cells that suppress the autoimmune response. The study will explore the mechanisms behind this antibody's effectiveness, particularly how it mobilizes myeloid-derived suppressor cells to protect insulin-producing cells in the pancreas. By applying findings from animal models to human T1D, the research aims to develop a novel therapeutic approach that could significantly improve treatment outcomes for patients.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking therapy that effectively reverses Type 1 Diabetes in patients.
How similar studies have gone: Previous research has shown promising results with similar immune-targeting approaches in animal models, but this specific application in humans is novel.
Where this research is happening
-
University of California at Davis
Davis, United States Active
Researchers
- Principal investigator: Ridgway, William M — University of California at Davis
- Study coordinator: Ridgway, William M
Related research
Other NIH-funded projects on the same topics.
-
Technological and Educational Approaches to Restore Hypoglycemia Awareness in Type 1 Diabetes
A two-arm study in adults with type 1 diabetes tests whether high-tech glucose control plus education or targeted training can help people regain awareness of low blood sugar.
-
Techniques for restoring awareness of low blood sugar in adults with type 1 diabetes
A randomized trial compares different approaches to help adults with type 1 diabetes recognize when their blood sugar is dipping so they can act quickly.
-
Treating impaired hypoglycemia awareness in type 1 diabetes with targeted education and technology
This study tests two treatment approaches to help adults with type 1 diabetes who often don’t realize their blood sugar is getting too low, using a mix of technology and education in two large groups.
-
Helping people with type 1 diabetes regain awareness of dangerous lows
A UK study tests two different approaches to help adults with type 1 diabetes recognize and respond to low blood sugar by comparing a high-tech insulin system with targeted education.
-
How the pancreas environment affects insulin-producing cells in type 1 diabetes
Researchers are studying how the surrounding tissue of the pancreas and its proteins influence insulin-producing cells in people with type 1 diabetes.
-
Understanding how hypoglycemia awareness changes in adults with type 1 diabetes and how automated insulin delivery and exercise might help restore it
This study will look at adults with type 1 diabetes to see how their awareness of low blood sugar evolves over time and whether automated insulin delivery and high-intensity exercise can help restore that awareness.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.